We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Pregnancy Test Tells When Conception Occurred

By LabMedica International staff writers
Posted on 29 Sep 2008
A one-step rapid pregnancy test also indicates an approximate date of conception.

The test is very simple and accurate. More...
Urine is applied to an absorbent sampler activating the test, which automatically calibrates itself. A "Wait” symbol on the liquid crystal display (LCD) display screen indicates the test is working. Within three minutes, an easy to read result is displayed. If the test is positive, "Pregnant” will be indicated in words on the display along with the Conception Indicator result. This is displayed as an estimate of how many weeks have occurred since conception: 1-2 weeks, 2-3 weeks or 3+ weeks.

Once a fertilized egg implants in the uterus wall, a woman's body produces the pregnancy hormone, human chorionic gonadotropin (hCG). This rapidly increases during the early weeks of pregnancy and is present in urine. It is this hormone that pregnancy tests detect when confirming a positive result. Clearblue (Waltham, MA, USA) launched the Clearblue digital pregnancy test with Conception Indicator--the only pregnancy test that is so advanced it is capable of telling a woman both if she is pregnant, and provide an indication when she might have conceived.

In laboratory tests, Clearblue digital pregnancy test is more than 99% accurate in detecting pregnancy, when used from the day the period is due. The Conception Indicator result is 92% accurate at indicating when a woman conceived, and when using the first urine of the day. As with the original Clearblue digital pregnancy test, the Conception Indicator is a one-step rapid test designed to be used once before disposal.

Clearblue launched the new test following extensive clinical studies to pinpoint the different levels of hCG required to estimate when conception occurred. Dr. Jayne Ellis, director of new product development at Clearblue commented, "The Conception Indicator is something we have been researching for a number of years, and the final product is unique. We are excited to be able to offer women more valuable information about their pregnancy as soon as the "pregnant” result is confirmed.”

Related Links:
Clearblue



Gold Member
Fibrinolysis Assay
HemosIL Fibrinolysis Assay Panel
Portable Electronic Pipette
Mini 96
New
Gold Member
Hybrid Pipette
SWITCH
ESR Analyzer
TEST1 2.0
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The Elecsys Dengue Ag assay is intended for the in vitro qualitative detection of dengue virus NS1 antigen in human serum and plasma (Photo courtesy of Roche)

Automated Test Distinguishes Dengue from Acute Fever-Causing Illnesses In 18 Minutes

Dengue fever remains the most common mosquito-borne viral infection worldwide, posing a major public health challenge as global cases continue to surge. In 2024 alone, more than 14.6 million infections... Read more

Hematology

view channel
Image: A schematic illustrating the coagulation cascade in vitro (Photo courtesy of Harris, N., 2024)

ADLM’s New Coagulation Testing Guidance to Improve Care for Patients on Blood Thinners

Direct oral anticoagulants (DOACs) are one of the most common types of blood thinners. Patients take them to prevent a host of complications that could arise from blood clotting, including stroke, deep... Read more

Microbiology

view channel
Image: EBP and EBP plus have received FDA 510(k) clearance and CE-IVDR Certification for use on the BD COR system (Photo courtesy of BD)

High-Throughput Enteric Panels Detect Multiple GI Bacterial Infections from Single Stool Swab Sample

Gastrointestinal (GI) infections are among the most common causes of illness worldwide, leading to over 1.7 million deaths annually and placing a heavy burden on healthcare systems. Conventional diagnostic... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.